Kubo M - Search Results

1

A novel germline mutation of TP53 with breast cancer diagnosed as Li-Fraumeni syndrome.

Kai M, Kubo M, Shikada S, Hayashi S, Morisaki T, Yamada M, Takao Y, Shimazaki A, Harada Y, Kaneshiro K, Mizuuchi Y, Shindo K, Nakamura M. Kai M, et al. Among authors: kubo m. Surg Case Rep. 2022 Oct 11;8(1):197. doi: 10.1186/s40792-022-01546-y. Surg Case Rep. 2022. PMID: 36219266 Free PMC article.

2

Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer.

Kubo M, Nakamura M, Tasaki A, Yamanaka N, Nakashima H, Nomura M, Kuroki S, Katano M. Kubo M, et al. Cancer Res. 2004 Sep 1;64(17):6071-4. doi: 10.1158/0008-5472.CAN-04-0416. Cancer Res. 2004. PMID: 15342389

3

Paclitaxel probably enhances cytotoxicity of natural killer cells against breast carcinoma cells by increasing perforin production.

Kubo M, Morisaki T, Matsumoto K, Tasaki A, Yamanaka N, Nakashima H, Kuroki H, Nakamura K, Nakamura M, Katano M. Kubo M, et al. Cancer Immunol Immunother. 2005 May;54(5):468-76. doi: 10.1007/s00262-004-0617-6. Epub 2004 Dec 9. Cancer Immunol Immunother. 2005. PMID: 15592829 Free PMC article.

4

Effects of docetaxel on antigen presentation-related functions of human monocyte-derived dendritic cells.

Nakashima H, Tasaki A, Kubo M, Kuroki H, Matsumoto K, Tanaka M, Nakamura M, Morisaki T, Katano M. Nakashima H, et al. Among authors: kubo m. Cancer Chemother Pharmacol. 2005 May;55(5):479-87. doi: 10.1007/s00280-004-0918-7. Epub 2005 Feb 23. Cancer Chemother Pharmacol. 2005. PMID: 15726369

5

Anti-patched-1 antibodies suppress hedgehog signaling pathway and pancreatic cancer proliferation.

Nakamura M, Kubo M, Yanai K, Mikami Y, Ikebe M, Nagai S, Yamaguchi K, Tanaka M, Katano M. Nakamura M, et al. Among authors: kubo m. Anticancer Res. 2007 Nov-Dec;27(6A):3743-7. Anticancer Res. 2007. PMID: 17970037 Free article.

6

[New therapeutic strategy for cancer targeting the hedgehog signaling pathway].

Nakamura M, Kubo M, Nagai S, Yamaguchi K, Tanaka M, Katano M. Nakamura M, et al. Among authors: kubo m. Gan To Kagaku Ryoho. 2007 Nov;34(12):1914-6. Gan To Kagaku Ryoho. 2007. PMID: 18219851 Japanese.

7

Novel link between estrogen receptor alpha and hedgehog pathway in breast cancer.

Koga K, Nakamura M, Nakashima H, Akiyoshi T, Kubo M, Sato N, Kuroki S, Nomura M, Tanaka M, Katano M. Koga K, et al. Among authors: kubo m. Anticancer Res. 2008 Mar-Apr;28(2A):731-40. Anticancer Res. 2008. PMID: 18507014 Free article.

8

The Hedgehog pathway is a possible therapeutic target for patients with estrogen receptor-negative breast cancer.

Kameda C, Tanaka H, Yamasaki A, Nakamura M, Koga K, Sato N, Kubo M, Kuroki S, Tanaka M, Katano M. Kameda C, et al. Among authors: kubo m. Anticancer Res. 2009 Mar;29(3):871-9. Anticancer Res. 2009. PMID: 19414322 Free article.

9

The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.

Tanaka H, Nakamura M, Kameda C, Kubo M, Sato N, Kuroki S, Tanaka M, Katano M. Tanaka H, et al. Among authors: kubo m. Anticancer Res. 2009 Jun;29(6):2147-57. Anticancer Res. 2009. PMID: 19528475 Free article.

10

Lipopolysaccharide (LPS) increases the invasive ability of pancreatic cancer cells through the TLR4/MyD88 signaling pathway.

Ikebe M, Kitaura Y, Nakamura M, Tanaka H, Yamasaki A, Nagai S, Wada J, Yanai K, Koga K, Sato N, Kubo M, Tanaka M, Onishi H, Katano M. Ikebe M, et al. Among authors: kubo m. J Surg Oncol. 2009 Dec 15;100(8):725-31. doi: 10.1002/jso.21392. J Surg Oncol. 2009. PMID: 19722233

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,775 results

Search Page

Filters